BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND PTPRK, DKFZp686C2268, 5796, ENSG00000152894, DKFZp779N1045, R-PTP-kappa, RP3-480J14_1 AND Prognosis
4562 results:

  • 1. Low-Level Expression of p-S6 Is Associated with Nodal Metastasis in Patients with Head and Neck Cutaneous Squamous Cell Carcinoma.
    Gómez-de Castro C; Santos-Juanes R; Nuñez-Gómez B; Fernández-Vega I; Vivanco B; Fernández-Velasco A; Reyes-García S; Carrero-Martín J; García-Pedrero JM; Rodrigo JP; González-Vela MDC; Santos-Juanes J; Galache C
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673889
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification of an anoikis-related gene signature and characterization of immune infiltration in skin cutaneous melanoma.
    Xu Z; Huang J; Shi W; Qi Y; Yuan F; Lin B
    Medicine (Baltimore); 2024 Apr; 103(17):e37900. PubMed ID: 38669429
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic Value of the Neutrophil-to-lymphocyte Ratio, Platelet-to- lymphocyte Ratio and Monocyte-to-lymphocyte Ratio in Melanoma Patients: A Cohort Study.
    Ertekin SS; Mangas C; Riquelme-Mc Loughlin C; Carrera C; Malvehy J; Puig S; Podlipnik S
    Acta Derm Venereol; 2024 Apr; 104():adv27571. PubMed ID: 38655656
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Impact of immune-related adverse events on survival outcomes in extensive-stage small cell lung cancer patients treated with immune checkpoint inhibitors.
    Nishimura T; Fujimoto H; Fujiwara T; Ito K; Fujiwara A; Yuda H; Itani H; Naito M; Kodama S; Furuhashi K; Yagi A; Saiki H; Yasuma T; Okano T; Tomaru A; Tanigawa M; Yoshida M; Hataji O; Ibata H; D'Alessandro-Gabazza CN; Gabazza EC; Kobayashi T
    Cancer Med; 2024 Apr; 13(8):e7188. PubMed ID: 38629295
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Could the mitotic count improve personalized prognosis in melanoma patients?
    Buja A; Rugge M; Cozzolino C; Dossi F; Zorzi M; Vecchiato A; de Luca G; Del Fiore P; Tropea S; dall'Olmo L; Rossi CR; Boccuzzo G; Mocellin S
    PLoS One; 2024; 19(4):e0302309. PubMed ID: 38626072
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A chest CT-based nomogram for predicting survival in acute myeloid leukemia.
    Yi X; Zhan H; Lyu J; Du J; Dai M; Zhao M; Zhang Y; Zhou C; Xu X; Fan Y; Li L; Dong B; Jiang X; Xiao Z; Zhou J; Zhao M; Zhang J; Fu Y; Chen T; Xu Y; Tian J; Liu Q; Zeng H
    BMC Cancer; 2024 Apr; 24(1):458. PubMed ID: 38609917
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Impact of concurrent medications on clinical outcomes of cancer patients treated with immune checkpoint inhibitors: analysis of Health Insurance Review and Assessment data.
    Hong S; Lee JH; Heo JY; Suh KJ; Kim SH; Kim YJ; Kim JH
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):186. PubMed ID: 38600328
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. ATP Citrate Lyase is a General Tumour Biomarker and Contributes to the Development of Cutaneous Squamous Cell Carcinoma.
    Luo R; Huang Y; Bai R; Liu M; Sun L; Wang X; Zheng Y
    Acta Derm Venereol; 2024 Apr; 104():adv23805. PubMed ID: 38590175
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Characteristics of long-survivor metastatic melanoma after polychemotherapy and interferon: a retrospective study.
    Py C; De Vito C; Tsantoulis P; Kaya G; Labidi-Galy SI; Dietrich PY
    Swiss Med Wkly; 2023 Dec; 153():3504. PubMed ID: 38579317
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic nomograms for predicting long-term overall survival in spindle cell melanoma: a population-based study.
    Lau WC; Huang L; Zheng X; Ming WK; Leong NC; Tak Wong Y; Yin Z; Yu H; Lyu J; Deng L
    Front Endocrinol (Lausanne); 2024; 15():1260966. PubMed ID: 38572477
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Divergent local and systemic antitumor response in primary uveal melanomas.
    Lucibello F; Lalanne AI; Le Gac AL; Soumare A; Aflaki S; Cyrta J; Dubreuil L; Mestdagh M; Salou M; Houy A; Ekwegbara C; Jamet C; Gardrat S; Le Ven A; Bernardeau K; Cassoux N; Matet A; Malaise D; Pierron G; Piperno-Neumann S; Stern MH; Rodrigues M; Lantz O
    J Exp Med; 2024 Jun; 221(6):. PubMed ID: 38563818
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Efficacy of Cemiplimab as Adjuvant or Neoadjuvant Therapy in the Treatment of Cutaneous Squamous Cell Carcinoma.
    Hiller A; Oxford M; Kulkarni P; Fornadley J; Lo A; Sivik J; Drabick J; Vakharia K
    Ann Plast Surg; 2024 Apr; 92(4S Suppl 2):S129-S131. PubMed ID: 38556660
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. CD146 as a prognostic marker in breast cancer: A meta-analysis.
    Sharma A; Somasundaram I; Chabaud MB
    J Cancer Res Ther; 2024 Jan; 20(1):193-198. PubMed ID: 38554320
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Efficiency and tolerance of second-line triple BRAF inhibitor/MEK inhibitor/anti-PD1 combined therapy in BRAF mutated melanoma patients with central nervous system metastases occurring during first-line combined targeted therapy: a real-life survey.
    Fabre M; Lamoureux A; Meunier L; Samaran Q; Lesage C; Girard C; Du Thanh A; Moulis L; Dereure O
    Melanoma Res; 2024 Jun; 34(3):241-247. PubMed ID: 38546723
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Trauma plays an important role in acral melanoma: A retrospective study of 303 patients.
    Huang R; Zhao M; Zhang G; Yang Y; Wang J; Zheng K; Li L; Su X; Zhao L; Wu Y; Zou Z
    Cancer Med; 2024 Apr; 13(7):e7137. PubMed ID: 38545846
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Effective Targeting of Melanoma Cells by Combination of Mcl-1 and Bcl-2/Bcl-x
    Peng Z; Gillissen B; Richter A; Sinnberg T; Schlaak MS; Eberle J
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542429
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Investigational Approaches for Treatment of Melanoma Patients Progressing After Standard of Care.
    Fletcher KA; Johnson DB
    Cancer J; 2024 Mar-Apr 01; 30(2):126-131. PubMed ID: 38527267
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic Melanoma.
    Los C; Klobuch S; Haanen JBAG
    Cancer J; 2024 Mar-Apr 01; 30(2):113-119. PubMed ID: 38527265
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Treatments on the horizon for locally advanced basal cell carcinoma.
    Idriss MH; Stull CM; Migden MR
    Cancer Lett; 2024 May; 589():216821. PubMed ID: 38521198
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Malignancy After Living Donor Liver Transplantation.
    Kobayashi T; Miura K; Ishikawa H; Sakata J; Takizawa K; Hirose Y; Toge K; Saito S; Abe S; Kawachi Y; Ichikawa H; Shimada Y; Takahashi Y; Wakai T; Kinoshita Y
    Transplant Proc; 2024 Apr; 56(3):660-666. PubMed ID: 38519268
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 229.